Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Stamerra CA, Di Giosia P, Giorgini P, De Feo M, Grassi D, Ferri C, Sahebkar A. Neurocognitive performance after PCSK9 inhibitor therapy: Current state of the evidence. J Neurosci Res 2017;96:762-764. [PMID: 29152786 DOI: 10.1002/jnr.24199] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2017] [Revised: 10/20/2017] [Accepted: 10/31/2017] [Indexed: 11/08/2022]

For:	Stamerra CA, Di Giosia P, Giorgini P, De Feo M, Grassi D, Ferri C, Sahebkar A. Neurocognitive performance after PCSK9 inhibitor therapy: Current state of the evidence. J Neurosci Res 2017;96:762-764. [PMID: 29152786 DOI: 10.1002/jnr.24199] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2017] [Revised: 10/20/2017] [Accepted: 10/31/2017] [Indexed: 11/08/2022]

Number	Cited by Other Article(s)
1	Proprotein Convertase Subtilisin-Kexin Type 9 (PCSK9) Inhibitors and Cardiovascular Risk: Does a Further Analysis of the Fourier Trial Suggest Changes in the Target of Lipid Lowering Therapy? High Blood Press Cardiovasc Prev 2018;25:5-7. [DOI: 10.1007/s40292-017-0244-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2017] [Accepted: 12/16/2017] [Indexed: 10/18/2022] Open Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse

Number

Cited by Other Article(s)

Proprotein Convertase Subtilisin-Kexin Type 9 (PCSK9) Inhibitors and Cardiovascular Risk: Does a Further Analysis of the Fourier Trial Suggest Changes in the Target of Lipid Lowering Therapy? High Blood Press Cardiovasc Prev 2018;25:5-7. [DOI: 10.1007/s40292-017-0244-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2017] [Accepted: 12/16/2017] [Indexed: 10/18/2022] Open